Axonics Price to Free Cash Flow Ratio 2017-2024 | AXNX

Axonics price to free cash flow ratio from 2017 to 2024. Price to free cash flow ratio can be defined as

Axonics Price to Free Cash Flow Ratio 2017-2024 | AXNX

Axonics price to free cash flow ratio from 2017 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
GE HealthCare Technologies (GEHC)$40.4B
Tempus AI (TEM)$7.9B
Inspire Medical Systems (INSP)$6.2B
Hims & Hers Health (HIMS)$3.5B
10x Genomics (TXG)$2.7B
Enovis (ENOV)$2.4B
Azenta (AZTA)$2.4B
Privia Health (PRVA)$2.3B
IRhythm Technologies (IRTC)$2.2B
Omnicell (OMCL)$2B
Clover Health Investments (CLOV)$1.5B
Schrodinger (SDGR)$1.4B
Phreesia (PHR)$1.4B
Standard BioTools (LAB)$753M
Fulgent Genetics (FLGT)$694M
Definitive Healthcare (DH)$538M
Health Catalyst (HCAT)$529M
Butterfly Network (BFLY)$406M
Talkspace (TALK)$343M
Pulmonx (LUNG)$329M
SOPHiA GENETICS SA (SOPH)$286M
TruBridge (TBRG)$183M
P3 Health Partners (PIII)$165M
American Well (AMWL)$147M
Augmedix (AUGX)$115M
EUDA Health Holdings (EUDA)$90M
Future Health ESG (FHLT)$65M
SHL Telemedicine (SHLT)$55M
HeartBeam (BEAT)$53M
111 (YI)$51M